|
Information For:
|
Revision BulletinVerapamil Hydrochloride Extended–Release Tablets
In accordance with the Rules and Procedures of the 2005–2010 Council of Experts, the Biopharmaceutics Expert Committee has revised the Verapamil Hydrochloride Extended–Release Tablets Monograph to revise Dissolution test 2. The Verapamil Hydrochloride Extended–Release Tablets Revision Bulletin supersedes the currently official monograph and will be incorporated into the USP 33–NF 28 Reissue. Should you have any questions, please contact Margareth Marques, Ph.D., (301–816–8106 or . Download the Verapamil Hydrochloride Extended–Release Tablets Monograph What's New
![]() USP recalled USP 33-NF 28 on Jan. 8, 2010. A reissue product will be available in April 2010.
PF 36(2), March-April 2010: IRAs and Errata (03/01/10) February Revision Bulletins (02/26/10) Protamine Monographs: Notice of Intent to Revise (02/26/10) New Draft Pending Standard for the month of February (02/26/10) PF 36(2), March-April 2010: Highlights (02/22/10) Calculation Tool for the Performance Verification Test (PVT) of Dissolution Assemblies (02/22/10) Performance of Equipment to Test Dissolution of Medications Further Assured (02/09/10) New Official Text (01/29/10) Related Resources |
||||||||||||||||||||||||||||
Copyright © 2010 The United States Pharmacopeial Convention
|
|||||||||||||||||||||||||||||